Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly prescribed for patients undergoing certain heart procedures.

Aggrastat is primarily used to prevent blood clots in patients with acute coronary syndrome or those undergoing percutaneous coronary intervention (PCI). This medication works by inhibiting platelet aggregation, which helps to maintain blood flow and reduce the risk of heart attacks. It is often administered in a hospital setting under medical supervision.

Common effects of Aggrastat may include bleeding, bruising, and injection site reactions. Some patients may experience nausea, dizziness, or low blood pressure. These effects are generally mild and temporary, but any severe or persistent symptoms should be reported to a healthcare provider.

Aggrastat should be handled with care, as it is intended for intravenous use only. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with a history of bleeding disorders or recent surgery should inform their doctor before using this medication.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is also important to avoid alcohol while using this medication, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication.